Evaluation of quercetin as a potential drug in osteosarcoma treatment

Kersten Berndt, Carmen Campanile, Roman Muff, Emanuel Strehler, Walter Born, Bruno Fuchs

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Background: Osteosarcoma is the most common malignant bone tumor in children and young adults. Since the introduction of chemotherapy, the 5-year survival rate of patients with non-metastatic osteosarcoma is ∼70%. The main problems in osteosarcoma therapy are the occurrence of metastases, severe side-effects and chemoresistance. Antiproliferative and apoptotic effects of quercetin were shown in several types of cancers, including breast cancer and lung carcinoma. Materials and Methods: The present study investigates the cytotoxic potential of quercetin, a dietary flavonoid, in a highly metastasizing human osteosarcoma cell line, 143B. Results: We found that quercetin induces growth inhibition, G2/M phase arrest, and apoptosis in the 143B osteosarcoma cell line. We also observed impaired adhesion and migratory potential after the addition of quercetin. Conclusion: Since quercetin has already been shown to have low side effects in a clinical phase I trial in advanced cancer patients, this compound may have considerable potential for osteosarcoma treatment.

Original languageEnglish (US)
Pages (from-to)1297-1306
Number of pages10
JournalAnticancer Research
Volume33
Issue number4
StatePublished - Apr 2013

Fingerprint

Quercetin
Osteosarcoma
Pharmaceutical Preparations
Therapeutics
Breast Neoplasms
Cell Line
Clinical Trials, Phase I
G2 Phase
Flavonoids
Cell Division
Young Adult
Lung Neoplasms
Neoplasms
Survival Rate
Apoptosis
Neoplasm Metastasis
Carcinoma
Bone and Bones
Drug Therapy
Growth

Keywords

  • 143B cells
  • Apoptosis
  • Cell-cycle arrest
  • Migration
  • Osteosarcoma
  • Quercetin

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Berndt, K., Campanile, C., Muff, R., Strehler, E., Born, W., & Fuchs, B. (2013). Evaluation of quercetin as a potential drug in osteosarcoma treatment. Anticancer Research, 33(4), 1297-1306.

Evaluation of quercetin as a potential drug in osteosarcoma treatment. / Berndt, Kersten; Campanile, Carmen; Muff, Roman; Strehler, Emanuel; Born, Walter; Fuchs, Bruno.

In: Anticancer Research, Vol. 33, No. 4, 04.2013, p. 1297-1306.

Research output: Contribution to journalArticle

Berndt, K, Campanile, C, Muff, R, Strehler, E, Born, W & Fuchs, B 2013, 'Evaluation of quercetin as a potential drug in osteosarcoma treatment', Anticancer Research, vol. 33, no. 4, pp. 1297-1306.
Berndt K, Campanile C, Muff R, Strehler E, Born W, Fuchs B. Evaluation of quercetin as a potential drug in osteosarcoma treatment. Anticancer Research. 2013 Apr;33(4):1297-1306.
Berndt, Kersten ; Campanile, Carmen ; Muff, Roman ; Strehler, Emanuel ; Born, Walter ; Fuchs, Bruno. / Evaluation of quercetin as a potential drug in osteosarcoma treatment. In: Anticancer Research. 2013 ; Vol. 33, No. 4. pp. 1297-1306.
@article{ac4c6465de8e428cacd2cb7f1c53333e,
title = "Evaluation of quercetin as a potential drug in osteosarcoma treatment",
abstract = "Background: Osteosarcoma is the most common malignant bone tumor in children and young adults. Since the introduction of chemotherapy, the 5-year survival rate of patients with non-metastatic osteosarcoma is ∼70{\%}. The main problems in osteosarcoma therapy are the occurrence of metastases, severe side-effects and chemoresistance. Antiproliferative and apoptotic effects of quercetin were shown in several types of cancers, including breast cancer and lung carcinoma. Materials and Methods: The present study investigates the cytotoxic potential of quercetin, a dietary flavonoid, in a highly metastasizing human osteosarcoma cell line, 143B. Results: We found that quercetin induces growth inhibition, G2/M phase arrest, and apoptosis in the 143B osteosarcoma cell line. We also observed impaired adhesion and migratory potential after the addition of quercetin. Conclusion: Since quercetin has already been shown to have low side effects in a clinical phase I trial in advanced cancer patients, this compound may have considerable potential for osteosarcoma treatment.",
keywords = "143B cells, Apoptosis, Cell-cycle arrest, Migration, Osteosarcoma, Quercetin",
author = "Kersten Berndt and Carmen Campanile and Roman Muff and Emanuel Strehler and Walter Born and Bruno Fuchs",
year = "2013",
month = "4",
language = "English (US)",
volume = "33",
pages = "1297--1306",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "4",

}

TY - JOUR

T1 - Evaluation of quercetin as a potential drug in osteosarcoma treatment

AU - Berndt, Kersten

AU - Campanile, Carmen

AU - Muff, Roman

AU - Strehler, Emanuel

AU - Born, Walter

AU - Fuchs, Bruno

PY - 2013/4

Y1 - 2013/4

N2 - Background: Osteosarcoma is the most common malignant bone tumor in children and young adults. Since the introduction of chemotherapy, the 5-year survival rate of patients with non-metastatic osteosarcoma is ∼70%. The main problems in osteosarcoma therapy are the occurrence of metastases, severe side-effects and chemoresistance. Antiproliferative and apoptotic effects of quercetin were shown in several types of cancers, including breast cancer and lung carcinoma. Materials and Methods: The present study investigates the cytotoxic potential of quercetin, a dietary flavonoid, in a highly metastasizing human osteosarcoma cell line, 143B. Results: We found that quercetin induces growth inhibition, G2/M phase arrest, and apoptosis in the 143B osteosarcoma cell line. We also observed impaired adhesion and migratory potential after the addition of quercetin. Conclusion: Since quercetin has already been shown to have low side effects in a clinical phase I trial in advanced cancer patients, this compound may have considerable potential for osteosarcoma treatment.

AB - Background: Osteosarcoma is the most common malignant bone tumor in children and young adults. Since the introduction of chemotherapy, the 5-year survival rate of patients with non-metastatic osteosarcoma is ∼70%. The main problems in osteosarcoma therapy are the occurrence of metastases, severe side-effects and chemoresistance. Antiproliferative and apoptotic effects of quercetin were shown in several types of cancers, including breast cancer and lung carcinoma. Materials and Methods: The present study investigates the cytotoxic potential of quercetin, a dietary flavonoid, in a highly metastasizing human osteosarcoma cell line, 143B. Results: We found that quercetin induces growth inhibition, G2/M phase arrest, and apoptosis in the 143B osteosarcoma cell line. We also observed impaired adhesion and migratory potential after the addition of quercetin. Conclusion: Since quercetin has already been shown to have low side effects in a clinical phase I trial in advanced cancer patients, this compound may have considerable potential for osteosarcoma treatment.

KW - 143B cells

KW - Apoptosis

KW - Cell-cycle arrest

KW - Migration

KW - Osteosarcoma

KW - Quercetin

UR - http://www.scopus.com/inward/record.url?scp=84876757293&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876757293&partnerID=8YFLogxK

M3 - Article

C2 - 23564766

AN - SCOPUS:84876757293

VL - 33

SP - 1297

EP - 1306

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 4

ER -